Follow
Yang Zhou
Yang Zhou
Verified email at duke.edu
Title
Cited by
Cited by
Year
Development of novel melanocortin receptor agonists based on the cyclic peptide framework of sunflower trypsin inhibitor-1
T Durek, PM Cromm, AM White, CI Schroeder, Q Kaas, J Weidmann, ...
Journal of medicinal chemistry 61 (8), 3674-3684, 2018
372018
Design of MC1R selective γ-MSH analogues with canonical amino acids leads to potency and pigmentation
Y Zhou, S Mowlazadeh Haghighi, I Zoi, JR Sawyer, VJ Hruby, M Cai
Journal of medicinal chemistry 60 (22), 9320-9329, 2017
212017
Novel approaches to the design of bioavailable melanotropins
Y Zhou, M Cai
Expert opinion on drug discovery 12 (10), 1023-1030, 2017
192017
Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH2, leads to hMC1R selectivity and pigmentation
SM Haghighi, Y Zhou, J Dai, JR Sawyer, VJ Hruby, M Cai
European journal of medicinal chemistry 151, 815-823, 2018
182018
Aged brains express less melanocortin receptors, which correlates with age-related decline of cognitive functions
Y Zhou, MK Chawla, JL Rios-Monterrosa, L Wang, MA Zempare, ...
Molecules 26 (20), 6266, 2021
122021
Development of macrocyclic peptidomimetics containing constrained α, α-dialkylated amino acids with potent and selective activity at human melanocortin receptors
F Merlino, Y Zhou, M Cai, A Carotenuto, AM Yousif, D Brancaccio, ...
Journal of medicinal chemistry 61 (9), 4263-4269, 2018
122018
Ghrelin receptor signaling in health and disease: a biased view
JD Gross, Y Zhou, LS Barak, MG Caron
Trends in Endocrinology & Metabolism 34 (2), 106-118, 2023
82023
Development of ligand-drug conjugates targeting melanoma through the overexpressed melanocortin 1 receptor
Y Zhou, S Mowlazadeh Haghighi, Z Liu, L Wang, VJ Hruby, M Cai
ACS Pharmacology & Translational Science 3 (5), 921-930, 2020
82020
Establishment of multi-stage intravenous self-administration paradigms in mice
LM Slosky, A Pires, Y Bai, NB Clark, ER Hauser, JD Gross, F Porkka, ...
Scientific reports 12 (1), 21422, 2022
72022
Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists
Y Zhou, AH Banday, VJ Hruby, M Cai
Molecules 24 (19), 3512, 2019
72019
Discovery of a functionally selective ghrelin receptor (GHSR1a) ligand for modulating brain dopamine
JD Gross, DW Kim, Y Zhou, D Jansen, LM Slosky, NB Clark, CR Ray, ...
Proceedings of the National Academy of Sciences 119 (10), e2112397119, 2022
52022
Measuring nonapoptotic caspase activity with a transgenic reporter in mice
PJ Nicholls, TF Pack, NM Urs, S Kumar, Y Zhou, G Ichim, JD Ginzel, ...
Eneuro 9 (5), 2022
42022
Development of Selective Peptide Ligands Targeting Melanocortin Receptors for Melanoma Prevention and Therapy
Y Zhou
The University of Arizona., 2019
12019
Ψ and χ Angle Constrains at the C-Terminus Trp Position of the Melanotropin Tetrapeptide Ac-His-d-Phe-Arg-Trp-NH2 Lead to Potent and Selective Agonists at …
Y Zhou, S Mowlazadeh Haghighi, JR Sawyer, VJ Hruby, M Cai
Journal of Medicinal Chemistry 66 (10), 6715-6724, 2023
2023
Conjugation of mcr1 ligand with cytotoxic drugs for treating skin cancer
M Cai, VJ Hruby, Y Zhou
US Patent App. 17/579,237, 2022
2022
Development of the MC1R Selective Ligands for the Melanoma Prevention
M Cai, Y Zhou, SM Haghighi, V Hruby
JOURNAL OF PEPTIDE SCIENCE 24, S69-S69, 2018
2018
DEVELOPMENT OF MC1R SELECTIVE LIGANDS AND CONJUGATES FOR THE PREVENTION OF SKIN CANCER AND MELANOMA IMAGING
M Cai, Y Zhou, S Mowlazadeh, J Sawyer, VJ Hruby, S Svensson
JOURNAL OF PEPTIDE SCIENCE 22, S44-S44, 2016
2016
Design, Synthesis and Test of Novel Lipidated Cysteine Analogs as Efficient TLR2/6 Agonists
Y Zhou, AH Banday, M Cai, V Hruby
Conformationally Constrained Ac-His-D-Nal (2’)-Nle-Trp-NH2 Analogues Leads to Selective Melanotropins
SM Haghighi, M Cai, Y Zhou, J Sawyer, B Lahtinen, C Chen, V Hruby
Design and Synthesis of a Novel Tetrapeptide with Improved Selectivity Towards the hMC1R
JR Sawyer, SM Haghighi, Y Zhou, K McLeod, VJ Hruby, M Cai
The system can't perform the operation now. Try again later.
Articles 1–20